Train harder · Free ship $75+ · Gear up now
Login Register
glp-1 prescriptions growth q1 2025

glp-1 prescriptions growth q1 2025 Market Size, Share Pharma Giants Bet on Next-Generation

SKU: 55185010386

4.2
EUR25.03 EUR52.03

Pay in 4 interest-free payments of $6.26 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Nov 11 - Nov 16

Description

Although the majority of first-time prescriptions occurred in the 45-64 age group, a higher proportion of patients with off-label prescriptions were female (off-label: 69%, on-label: 61%) and between 18-25 (off-label: 30%, on-label: 22%)

glp-1 prescriptions growth q1 2025 Market Size, Share Pharma Giants Bet on Next-Generation

Save that energy for the things that really matter: raising a family, thriving in your career, or pursuing your passions

glp-1 prescriptions growth q1 2025 Market Size, Share Pharma Giants Bet on Next-Generation

In the international survey, 75.2% of participants used semaglutide and 19.9% used tirzepatide

glp-1 prescriptions growth q1 2025 Market Size, Share Pharma Giants Bet on Next-Generation

Nausea severity varies widely based on individual sensitivity, dietary choices, and dose timing

glp-1 prescriptions growth q1 2025 Market Size, Share Pharma Giants Bet on Next-Generation
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products